(815) Thiola: payments to doctors
Payments that named (815) Thiola as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $459K
- Providers
- 4,286
- Transactions
- 10,906
- Average per transaction
- $42
The per-transaction average — $42 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,286 providers the average total is $107, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Retrophin, Inc. | $251,216 | 54.7% |
| Travere Therapeutics, Inc. | $207,907 | 45.3% |